셀리악병 시장 보고서(2026년)

Celiac disease is an autoimmune disorder in which the ingestion of gluten triggers immune-mediated damage to the small intestine, causing malabsorption and various symptoms. Diagnosis is typically made through blood tests and intestinal biopsy, and the primary treatment is a lifelong gluten-free diet to heal the intestine and prevent complications.

The main treatments for celiac disease include infliximab, larazotide acetate, gluten-free diets, and others. Infliximab is a monoclonal antibody that reduces inflammation by blocking tumor necrosis factor-alpha (TNF-a). It can be administered orally or parenterally and is used by end-users such as hospitals, home care providers, and others.

Tariffs have influenced the celiac disease market by raising costs for gluten-free raw materials, specialty foods, diagnostic kits, and pharmaceutical treatments. Gluten-free food products and biologic drug segments are most affected, particularly in North America and Europe where cross-border food and healthcare trade is high. Homecare and hospital channels experience price pressure. However, tariffs are promoting domestic gluten-free food production and localized pharmaceutical manufacturing.

The celiac disease market research report is one of a series of new reports from The Business Research Company that provides celiac disease market statistics, including celiac disease industry global market size, regional shares, competitors with a celiac disease market share, detailed celiac disease market segments, market trends and opportunities, and any further data you may need to thrive in the celiac disease industry. This celiac disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The celiac disease market size has grown rapidly in recent years. It will grow from $0.78 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to autoimmune disease awareness, improved diagnostics, dietary management adoption, hospital gastroenterology care, patient advocacy.

The celiac disease market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to novel drug development, gluten-free food innovation, personalized nutrition, early screening programs, microbiome research. Major trends in the forecast period include rising adoption of gluten-free diets, growth of packaged gluten-free foods, expansion of drug-based therapies, increased disease awareness and diagnosis, focus on microbiome-based treatments.

The growth of personalized medicine is expected to drive the expansion of the celiac disease market in the coming years. Personalized medicine is a healthcare approach that tailors medical care based on an individual's genetic profile, environment, and lifestyle. The rising demand for personalized medicine is fueled by increased access to genetic testing, enabling more accurate diagnoses and targeted treatments customized for each patient. Personalized medicine supports celiac disease management by allowing precise identification of genetic markers and individual immune responses, leading to more effective and individualized treatment strategies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, up from 6 approvals in 2022. Therefore, the growth of personalized medicine is driving the celiac disease market.

Major companies in the celiac disease market are focusing on advanced therapies such as anti-interleukin-15 (IL-15) antibodies, designed to reduce tissue damage by modulating overactive immune cell activity. Anti-IL-15 antibodies are specialized proteins that inhibit IL-15, a cytokine involved in immune response, helping to control inflammation and immune-mediated tissue injury. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track designation for TEV-53408, an investigational anti-IL-15 monoclonal antibody. This therapy is being developed for individuals with celiac disease who continue to experience symptoms despite adhering to a gluten-free diet. TEV-53408 functions by blocking IL-15, which plays a key role in triggering intestinal immune damage in celiac patients, and is currently undergoing Phase 2a clinical trials to evaluate its safety and efficacy.

In May 2025, Targeted Genomics, a US-based company specializing in celiac disease genetics and wellness, partnered with OraSure Technologies to offer direct-to-consumer (DTC) genetic testing for celiac disease. This collaboration allows Targeted Genomics to leverage OraSure's expertise in diagnostics to provide individuals with personalized genetic risk information, enhancing proactive health management. OraSure Technologies is a US-based provider of celiac disease diagnostic solutions.

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the celiac disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The celiac disease market consists of revenues earned by entities by providing services such as diagnostic testing services, histopathology services, dietary consultation, nutrition counseling, and food certification. The market value includes the value of related goods sold by the service provider or included within the service offering. The celiac disease market also includes sales of gluten-free foods, diagnostic test kits, nutritional supplements, gluten detection devices, and probiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Celiac Disease Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses celiac disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for celiac disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The celiac disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment: Larazotide Acetate; Gluten Free Diet; Other Treatments
• 2) By Route Of Administration: Oral; Parenteral
• 3) By End Users: Hospitals; Homecare; Other End-Users
• Subsegments:
• 1) By Larazotide Acetate: Clinical Trial Phase Products; Oral Capsule Formulation; Adult Celiac Patients; Pediatric Investigational Use; Monotherapy And Combination Therapy
• 2) By Gluten Free Diet: Packaged Gluten-Free Foods; Gluten-Free Bakery Products; Gluten-Free Snacks; Gluten-Free Nutritional Supplements; Gluten-Free Beverages
• 3) By Other Treatments: Corticosteroids; Immunosuppressive Drugs; Enzyme Therapies; Monoclonal Antibodies; Probiotics And Microbiome Modulators
• Companies Mentioned: Pfizer Inc.; Sanofi SA; Novartis AG; Takeda Pharmaceutical Company Ltd.; Chugai Pharmaceutical Co. Ltd.; Dr Falk Pharma GmbH; Theriva Biologics Inc.; Equillium Inc.; Immunic Inc.; Barinthus Biotherapeutics Plc; Allero Therapeutics; Anokion SA; Mozart Therapeutics; ImmunogenX; Topas Therapeutics GmbH; Parvus Therapeutics Inc.; AMYRA Biotech AG; Provention Limited; Precigen Inc.; Zedira GmbH; AnTolRx Inc.; Nemysis Ltd.; Entero Therapeutics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Celiac Disease Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Celiac Disease Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Celiac Disease Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Celiac Disease Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Sustainability, Climate Tech & Circular Economy
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Gluten-Free Diets
  • 4.2.2 Growth Of Packaged Gluten-Free Foods
  • 4.2.3 Expansion Of Drug-Based Therapies
  • 4.2.4 Increased Disease Awareness And Diagnosis
  • 4.2.5 Focus On Microbiome-Based Treatments

5. Celiac Disease Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Gastroenterology Clinics
• 5.3 Homecare Patients
• 5.4 Specialty Food Manufacturers
• 5.5 Nutritional Therapy Providers

6. Celiac Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Celiac Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Celiac Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Celiac Disease Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Celiac Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Celiac Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Celiac Disease Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Celiac Disease Market Segmentation

• 9.1. Global Celiac Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Larazotide Acetate, Gluten Free Diet, Other Treatments
• 9.2. Global Celiac Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Parenteral
• 9.3. Global Celiac Disease Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Homecare, Other End-Users
• 9.4. Global Celiac Disease Market, Sub-Segmentation Of Larazotide Acetate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy
• 9.5. Global Celiac Disease Market, Sub-Segmentation Of Gluten Free Diet, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages
• 9.6. Global Celiac Disease Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

10. Celiac Disease Market Regional And Country Analysis

• 10.1. Global Celiac Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Celiac Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Celiac Disease Market

• 11.1. Asia-Pacific Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Celiac Disease Market

• 12.1. China Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Celiac Disease Market

• 13.1. India Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Celiac Disease Market

• 14.1. Japan Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Celiac Disease Market

• 15.1. Australia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Celiac Disease Market

• 16.1. Indonesia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Celiac Disease Market

• 17.1. South Korea Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Celiac Disease Market

• 18.1. Taiwan Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Celiac Disease Market

• 19.1. South East Asia Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Celiac Disease Market

• 20.1. Western Europe Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Celiac Disease Market

• 21.1. UK Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Celiac Disease Market

• 22.1. Germany Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Celiac Disease Market

• 23.1. France Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Celiac Disease Market

• 24.1. Italy Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Celiac Disease Market

• 25.1. Spain Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Celiac Disease Market

• 26.1. Eastern Europe Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Celiac Disease Market

• 27.1. Russia Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Celiac Disease Market

• 28.1. North America Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Celiac Disease Market

• 29.1. USA Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Celiac Disease Market

• 30.1. Canada Celiac Disease Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Celiac Disease Market

• 31.1. South America Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Celiac Disease Market

• 32.1. Brazil Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Celiac Disease Market

• 33.1. Middle East Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Celiac Disease Market

• 34.1. Africa Celiac Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Celiac Disease Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Celiac Disease Market Regulatory and Investment Landscape

36. Celiac Disease Market Competitive Landscape And Company Profiles

• 36.1. Celiac Disease Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Celiac Disease Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Celiac Disease Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Takeda Pharmaceutical Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Chugai Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Celiac Disease Market Other Major And Innovative Companies

• Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH

38. Global Celiac Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Celiac Disease Market

40. Celiac Disease Market High Potential Countries, Segments and Strategies

• 40.1 Celiac Disease Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Celiac Disease Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Celiac Disease Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer